FIELD: medicine, oncology, radiation medicine. SUBSTANCE: invention proposes to use ephazol as a drug at the dose 15-50 mg/kg body mass of experimental animal. At radiation-induced immunodeficiency ephazol is administrated in 15-20 min after irradiation and at cytostatic one - in 24 h after administration of cytostatic agent. Method ensures to arrest the state of the secondary immunodeficiency by stimulation both humoral and cellular link of the immunity. Invention can be used for correction of radiation and cytostatic immunodeficiency. EFFECT: enhanced effectiveness of correction. 3 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION POSSESSING IMMUNOTROPIC ACTIVITY | 2009 |
|
RU2406524C1 |
MEDICATION, WHICH POSSESES IMMUNOSTIMULATING ACTIVITY | 2009 |
|
RU2403054C1 |
IMMUNOSTIMULATING AGENT | 1993 |
|
RU2077339C1 |
MEDICATION POSSESSING IMMUNOSTIMULATION ACTION | 2008 |
|
RU2406517C2 |
DIHYDROCHLORIDES OF 9-SUBSTITUTED 9-SUBSTITUTED 2-(1-ADAMANTYL)IMIDAZOL(1,2-ALPHA)BENZIMIDAZOLS DISPLAYING IMMUNODEPRESSING ACTIVITY | 0 |
|
SU1143039A1 |
AGENT POSSESSING IMMUNOCORRECTIVE ACTION IN CYTOSTATIC IMMUNOSUPPRESSION | 2011 |
|
RU2482861C1 |
METHOD FOR EXPERIMENTAL ASSESSMENT OF MILLIMETRE-RANGE ELECTROMAGNETIC WAVES (EHF) EFFECT | 2012 |
|
RU2529694C2 |
AGENT HAVING IMMUNODEPREMSSION ACTION | 0 |
|
SU933096A1 |
IMMUNOMODULATOR | 2003 |
|
RU2253445C1 |
PYRIMIDINE DERIVATIVE WITH ANTIMICROBIAL AND IMMUNOTROPIC ACTIVITY | 2022 |
|
RU2793336C1 |
Authors
Dates
1999-09-27—Published
1996-12-17—Filed